StreetInsider.com News Articles

Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026

Wed, 14 Oct 2026 08:00:00 -0400

New Innovations Designed to Advance Patient-Specific Planning and Connected Surgical Workflows

AUDUBON, Pa., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will highlight its latest spine innovations at the 41^st Annual North American Spine Society (NASS) Meeting in San Antonio, Texas, from October 14-17.

Globus Medical is continuing to expand its integrated spine ecosystem with technologies designed to connect patient-specific planning, implant solutions, and surgical execution across a range of spinal procedures. At NASS, the company will showcase SCRIPT™, its new patient-specific spinal implant platform, alongside the

Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026

Wed, 14 Oct 2026 08:00:00 -0400

New Innovations Designed to Advance Patient-Specific Planning and Connected Surgical Workflows

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

Mon, 12 Oct 2026 16:01:00 -0400

AUDUBON, Pa., Oct. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended September 30, 2026 after the market close on Thursday, November 5, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.

Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call live via webcast on the Investors page of Globus Medical’s

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

Mon, 12 Oct 2026 16:01:00 -0400

Globus Medical (GMED) PT Lowered to $85 at RBC Capital

Thu, 01 Oct 2026 06:52:04 -0400

RBC Capital analyst Shagun Singh lowered the price target on Globus Medical (NYSE: GMED) to $85.00 (from $115.00) while maintaining a Outperform rating.

BTIG Reiterates Neutral Rating on Globus Medical (GMED)

Fri, 18 Sep 2026 06:05:46 -0400

BTIG analyst Ryan Zimmerman reiterated a Neutral rating on Globus Medical (NYSE: GMED).

The analyst commented: "We took a closer look at the underperformance of Nevro, GMED's recently acquired spinal cord stimulation (SCS) asset, evaluating internal execution, competitive dynamics, and broader regulatory dynamics that could be impacting demand. Given the volatility in Nevro's performance since the sales force compensation transition late in FY25, it raises the question: where does Nevro go from here? Perhaps most pointedly, we're also asking why GMED bought Nevro in the first place, and if it can be woven into the Excelsius ecosystem in a meaningful way

Form 4 GLOBUS MEDICAL INC For: Sep 15 Filed by: TOBIN JAMES R

Wed, 16 Sep 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260916/27070773.html

Form 144 GLOBUS MEDICAL INC Filed by: TOBIN JAMES R

Tue, 15 Sep 2026 14:29:00 -0400

si-local-file:///var/storage/secattach/20260915/27064369.html

Globus Medical wins CE mark for Excelsius3D imaging system in EU

Thu, 03 Sep 2026 16:30:14 -0400

Globus Medical, Inc. (NYSE: GMED) announced that its Excelsius3D imaging system has received CE marking, allowing the company to begin commercial sales of the device in the European Union and United Kingdom.

The Excelsius3D is a mobile imaging platform that combines 3D cone-beam computed tomography, 2D fluoroscopy, and digital radiography in a single system. The device is designed for intraoperative use and is compatible with Globus Medical's ExcelsiusGPS robotic navigation system.

The system can operate as a stand-alone intraoperative imaging platform or as an integrated component alongside ExcelsiusGPS. The device features omnidirectional wheels and a compact design intended to facilitate movement within

Globus Medical Announces CE Mark for Excelsius3D™ Imaging System

Thu, 03 Sep 2026 16:30:00 -0400

Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union

AUDUBON, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that the Excelsius3D™ intelligent 3-in-1 imaging system is now CE marked for commercial sale in the European Union and the United Kingdom. The addition of Excelsius3D™ expands the company’s Excelsius™ Ecosystem of enabling technologies and further enhances the capabilities of the ExcelsiusGPS™ robotic navigation system in the European Union.

Excelsius3D™ is an intelligent, mobile imaging platform that combines 3D cone-beam computed tomography (CT), 2D fluoroscopy,

Globus Medical Announces CE Mark for Excelsius3D™ Imaging System

Thu, 03 Sep 2026 16:30:00 -0400

Excelsius3D™ – Intelligent 3-in-1 Imaging System Expands Excelsius™ Ecosystem in the European Union

Excelsius3D™ is an intelligent, mobile imaging platform that combines 3D cone-beam computed tomography (CT), 2D fluoroscopy,

Globus Medical acquires AI health firm Higgs Boson Health

Wed, 26 Aug 2026 17:57:27 -0400

Globus Medical, Inc. (NYSE: GMED) has acquired Higgs Boson Health, a digital healthcare company based in Durham, N.C. that was incubated out of Duke University, according to a press release dated Aug. 26, 2026.

Higgs Boson Health employs software developers and AI scientists. Globus Medical said the acquisition is intended to support patient and provider experience across the full episode of care within its musculoskeletal technology business.

Keith Pfeil, President and Chief Executive Officer, said the Higgs Boson technology will become part of the company's surgical intelligence pillar, "bringing together outcomes and analytics in a closed-loop manner that fosters continuous learning, integrating

Globus Medical acquires AI health firm Higgs Boson Health

Wed, 26 Aug 2026 17:57:27 -0400

Globus Medical acquires AI health firm Higgs Boson Health

Wed, 26 Aug 2026 17:57:27 -0400

Globus Medical acquires AI health firm Higgs Boson Health

Wed, 26 Aug 2026 17:57:27 -0400

Globus Medical Announces Acquisition of Higgs Boson Health to Transform Healthcare Experience Through AI-Driven Digital Solutions